Research map: Context as Contraindication: Ethical Challenges of Psychedelics and Other Neuroplasticity-Enhancing Drugs

Back to the article

Papers in this map

  1. Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice · Madhukar H. Trivedi · 2006 · 3927 citations · Cited by this paper
  2. A Moratorium on Implantable Non-Medical Neurotech Until Effects on the Mind are Properly Understood · 2025 · Related
  3. THE INVERSE CARE LAW · Julian Tudor Hart · 1971 · 3304 citations · Cited by this paper
  4. The Ghosts of Psychedelic Science: Haunting and Moral Repair · 2025 · Related
  5. The alliance in adult psychotherapy: A meta-analytic synthesis. · Christoph Flückiger · 2018 · 1771 citations · Cited by this paper
  6. Ethical Considerations Toward Harmonizing Human and Machine Agency in Embodied Neurotechnologies · 2026 · Related
  7. REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics · Robin Lester Carhart-Harris · 2019 · 1237 citations · Cited by this paper
  8. Precautionary Principle and Post-Mortem Brain Resuscitation · 2025 · Related
  9. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial · Fernanda Palhano-Fontes · 2018 · 852 citations · Cited by this paper
  10. Regulating Next-Generation Implantable Brain-Computer Interfaces: Recommendations for Ethical Development and Implementation · 2026 · Related
  11. Rethinking cultural competence · Laurence J. Kirmayer · 2012 · 710 citations · Cited by this paper
  12. The Psychological Risks of BCI-LLM Cognitive “Enhancement” · 2025 · Related
  13. Psychedelics and the essential importance of context · Robin Lester Carhart-Harris · 2018 · 670 citations · Cited by this paper
  14. The Enduring Promise of Personalising Patient Preference Prediction · 2026 · Related
  15. Single-Dose Psilocybin Treatment for Major Depressive Disorder · Charles L. Raison · 2023 · 543 citations · Cited by this paper
  16. Damage and Restoration of Personal Identity in Deep Brain Stimulation: A Relational Perspective · 2025 · Related
  17. Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology · Ido Hartogsohn · 2016 · 487 citations · Cited by this paper
  18. Conflicting Interests and New Frontiers: A Role for Virtue Ethics in Cutting Edge Brain Research with Humans · 2025 · Related
  19. Towards an understanding of psychedelic-induced neuroplasticity · Abigail E. Calder · 2022 · 328 citations · Cited by this paper
  20. When Are Psychiatric Patients Considered Less Credible? Implications for the Epistemic Injustice Debate · 2026 · Related
  21. Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response · Paul W. Andrews · 2015 · 288 citations · Cited by this paper
  22. Treatment of SSRI-Resistant Depression: A Meta-Analysis Comparing Within- Versus Across-Class Switches · George I. Papakostas · 2007 · 284 citations · Cited by this paper
  23. Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics · Cato M. H. de Vos · 2021 · 273 citations · Cited by this paper
  24. Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics · David E. Olson · 2018 · 262 citations · Cited by this paper
  25. REACTIONS TO PSILOCYBJN ADMINISTERED IN A SUPPORTIVE ENVIRONMENT · Timothy Leary · 1963 · 248 citations · Cited by this paper
  26. Do Gender and Racial Differences Between Patient and Therapist Affect Therapeutic Alliance and Treatment Retention in Adolescents? · Matthew B. Wintersteen · 2005 · 248 citations · Cited by this paper
  27. Post-Truth · Steve Fuller · 2018 · 248 citations · Cited by this paper
  28. Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression · Roberta R. Murphy · 2022 · 244 citations · Cited by this paper
  29. The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion · Jamilah R. George · 2019 · 231 citations · Cited by this paper
  30. Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment · Silvia Alboni · 2015 · 223 citations · Cited by this paper
  31. Extended difficulties following the use of psychedelic drugs: A mixed methods study · Jules Evans · 2023 · 188 citations · Cited by this paper
  32. Psychiatrist effects in the psychopharmacological treatment of depression · Kevin M. McKay · 2006 · 170 citations · Cited by this paper
  33. The double edged sword of neural plasticity: Increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover · Igor Branchi · 2010 · 160 citations · Cited by this paper
  34. Expectancy and the Treatment of Depression: A Review of Experimental Methodology and Effects on Patient Outcome · Bret R. Rutherford · 2010 · 145 citations · Cited by this paper
  35. Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics · Otto Simonsson · 2023 · 137 citations · Cited by this paper
  36. Set, Setting, and Matrix · Betty Grover Eisner · 1997 · 129 citations · Cited by this paper
  37. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): Part 2: Study Outcomes · Robert H. Howland · 2008 · 117 citations · Cited by this paper
  38. Trajectories of Depression Severity in Clinical Trials of Duloxetine · Ralitza V. Gueorguieva · 2011 · 117 citations · Cited by this paper
  39. Social Inequalities in Response to Antidepressant Treatment in Older Adults · Alex H. Cohen · 2006 · 114 citations · Cited by this paper

Source: OpenAlex (CC0)